Lisata Therapeutics Stock Investor Sentiment

LSTA Stock  USD 2.75  1.15  29.49%   
About 62% of Lisata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Lisata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Lisata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lisata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
over a month ago at investing.com         
Solid Biosciences CEO Alexander Cumbo sells 62,236 in stock
Investing News at Macroaxis
over a month ago at businesswire.com         
Revelation Biosciences Inc. Announces Exercise of Warrants for 4 Million in Gross Proceeds
businesswire News
over a month ago at gurufocus.com         
Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Revelation Biosciences Inc. Announces Exercise of Warrants for 4 Million in Gross Proceeds
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
Senti Biosciences, Inc. Announces Oversubscribed 37.6 Million Private Placement Equity Financing
Yahoo News
over a month ago at gurufocus.com         
Senti Biosciences, Inc. Announces Oversubscribed 37.6 Million Private Placement Equity Financing
Gurufocus Stories at Macroaxis
over a month ago at simplywall.st         
Is Sino-Agri Leading Biosciences Co.,Ltds Latest Stock Performance A Reflection Of Its Financial Hea...
Simply Wall St News at Macroaxis
over a month ago at thefly.com         
Bright Minds Biosciences participates in a conference call with Truist DRUG
news
over a month ago at insidermonkey.com         
Why Neurocrine Biosciences Is the Most Profitable Pharmaceutical Stock Right Now?
insidermonkey News
over a month ago at gurufocus.com         
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Vinva Investment Management Ltd Increases Position in Neurocrine Biosciences, Inc.
news
over a month ago at thelincolnianonline.com         
Celebrus Technologies Reaches New 1-Year High Heres Why
news
over a month ago at thelincolnianonline.com         
Evelo Biosciences Target of Unusually High Options Trading
news
over a month ago at simplywall.st         
Swelling losses havent held back gains for LigaChem Biosciences shareholders since theyre up 256 per...
Simply Wall St News at Macroaxis
over a month ago at finance.yahoo.com         
Marvel Biosciences Announces Promising New Data from Rett Syndrome Study and Plans to Discuss Orphan...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.

Lisata Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.